Literature DB >> 2170215

Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy.

T J Allen1, M E Cooper, R C O'Brien, L A Bach, B Jackson, G Jerums.   

Abstract

The interrelationships of sodium and volume status, atrial natriuretic peptide (ANP), plasma renin activity (PRA), insulinlike growth factor I (IGF-I), and kidney weight and their influence on glomerular filtration rate (GFR) were investigated in rats during the first 4 wk of streptozocin-induced diabetes (STZ-D). In each of three experiments, untreated diabetic rats were compared with nondiabetic control rats and rats with varying degrees of glycemic control during insulin therapy. The first experiment evaluated exchangeable sodium, plasma volume, and GFR. In untreated diabetic rats, exchangeable sodium and plasma volume, but not GFR, were increased by approximately 25% compared with control rats. Insulin-treated diabetic rats with plasma glucose levels ranging from 12 to 30 mM had increased GFR, whereas exchangeable sodium and plasma volume were reduced toward control values. Daily insulin therapy, titrated to maintain euglycemia, further reduced exchangeable sodium and plasma volume and decreased but did not normalize GFR. The second experiment evaluated the relationship between vasoactive hormones and GFR. In untreated diabetic rats, plasma ANP levels increased 89% and urinary cyclic GMP (cGMP) excretion increased 94%, with an 85% decrease in PRA, whereas GFR was unchanged. Moderate hyperglycemia (plasma glucose 12-30 mM) was associated with normalized plasma ANP levels and urinary cGMP excretion, a 52% decrease in PRA, and a 13% increase in GFR. The third experiment studied serial changes in food and water intake and vasoactive hormones and end-point measurement of kidney weight, GFR, and plasma IGF-I. In the untreated diabetic group, urinary cGMP excretion was significantly elevated after 3 wk, whereas the reduction in PRA levels was apparent after 1 wk.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170215     DOI: 10.2337/diab.39.10.1182

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

Authors:  David León Jiménez; David Z I Cherney; Petter Bjornstad; Luis Castilla-Guerra; José Pablo Miramontes González
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

2.  Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients.

Authors:  T Pelikánová; I Smrcková; J Krízová; J Stríbrná; V Lánská
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Is human insulin without effect in the diabetic rat?

Authors:  O Torffvit
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.

Authors:  B J Davis; C I Johnston; L M Burrell; W C Burns; E Kubota; Z Cao; M E Cooper; T J Allen
Journal:  Diabetologia       Date:  2003-06-28       Impact factor: 10.122

5.  Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.

Authors:  Elif I Ekinci; Georgina Thomas; David Thomas; Cameron Johnson; Richard J Macisaac; Christine A Houlihan; Sue Finch; Sianna Panagiotopoulos; Chris O'Callaghan; George Jerums
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 17.152

6.  Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats.

Authors:  H Wehner; G Nelischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Urinary protein profiles in a rat model for diabetic complications.

Authors:  Daniela M Schlatzer; Jean-Eudes Dazard; Moyez Dharsee; Rob M Ewing; Serguei Ilchenko; Ian Stewart; George Christ; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-06-04       Impact factor: 5.911

8.  Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

Authors:  E Jungmann; A Felber; S Graeber; U Hillmann; T Haak; K D Palitzsch; K H Usadel
Journal:  Clin Investig       Date:  1993-08

9.  The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.

Authors:  W P Chang; E Dimitriadis; T Allen; M E Dunlop; M Cooper; R G Larkins
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

10.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; L P van den Heuvel; J H Veerkamp; J H Berden
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.